Navigation Links
Lumenis VersaPulse PowerSuite

ProductsLumenis VersaPulse PowerSuite
Company Lumenis, Inc.
Item Lumenis VersaPulse PowerSuite
Features 
  • Immediate removal of tissue and symptoms.
  • Virtually bloodless and minimally invasive technique.
  • Typically one minute per gram is the average time
  • Short catheterization time.
  • Fewer complications.
  • Shorter convalescence.
  • Cost-effective solutions - hospitals gain unmatched economic benefits by utilizing the multipurpose holmium laser for stones, strictures, tumors AND BPH treatment.
Description HoLAP is a safe, effective and relatively bloodless procedure for immediate resolution of BPH symptoms. It is easy to learn and can be performed in less than an hour in an outpatient setting with few if any patient complications. Surgeons can quickly master the procedure, minimize OR time and use a familiar technology with which they are comfortable. Patients experience few complications including no blood loss, no transfusions, no catheters after release and a quick return to normal activity. Facilities enjoy the economic benefits of utilizing a multipurpose system for many applications.
Info Lumenis, Inc.
Customer Service: 877-lumenis
Web site: http://www.lumenis.com

Related medicine products :

1. Lumenis 950 Slit Lamp
2. Lumenis 1000 Integrated Slit Lamp
3. Lumenis One Multi-Spot Nd:YAG Module
4. VersaPulse® 20 Watt
5. VersaPulse® 60 Watt
6. VersaPulse® 100 Watt
7. VersaPulse® 80/100 Watt
8. VersaPulse 60 Watt
9. VersaPulse 20 Watt
10. VersaPulse 80/100 Watt
11. VersaPulse 100 Watt
Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2CVS pharmacy Rewards Shoppers For Passing on Plastic Bags 60074 1CVS pharmacy Rewards Shoppers For Passing on Plastic Bags 60074 2CVS pharmacy Rewards Shoppers For Passing on Plastic Bags 60074 3Charitable Giving for U S Health Care Rises a Tepid 24241 Million in 2008 While Canadian Charitable Giving Plunges 13 Percent Association for Hea 60072 1Charitable Giving for U S Health Care Rises a Tepid 24241 Million in 2008 While Canadian Charitable Giving Plunges 13 Percent Association for Hea 60072 2Charitable Giving for U S Health Care Rises a Tepid 24241 Million in 2008 While Canadian Charitable Giving Plunges 13 Percent Association for Hea 60072 3Charitable Giving for U S Health Care Rises a Tepid 24241 Million in 2008 While Canadian Charitable Giving Plunges 13 Percent Association for Hea 60072 4Oxygen Biotherapeutics Inc Expands Board of Directors 14593 1Oxygen Biotherapeutics Inc Expands Board of Directors 14593 2